Etopiryna (300mg + 50mg + 100mg) x 10 tabl.

How to use: Use as directed by your doctor
Detailed instructions for use can be found in the leaflet included in the package.

Storage: Store at ambient temperature

Caffeine

Zakłady Farmaceutyczne Polpharma S.A.

Zakłady Farmaceutyczne Polpharma S.A.,
street Pelplińska 19,
83-200 Starogard Gdański,
PL

The medicinal product should not be used in patients taking oral antidiabetic drugs from the sulfonylurea group, due to the risk of increased hypoglycemic effect, and in patients taking anti-gout drugs. The product should be used with caution in patients with impaired renal function and chronic renal failure. In patients with juvenile rheumatoid arthritis and/or systemic lupus erythematosus and liver failure, the product should be used with caution because the toxicity of salicylates increases; liver function should be monitored in these patients. Taking the lowest effective dose for the shortest period necessary to relieve symptoms reduces the risk of side effects. The product should be discontinued 5 to 7 days before the planned surgical procedure,due to the risk of prolonged bleeding time both during and after the procedure. Caution should be exercised when using methotrexate in doses lower than 15 mg/week due to the increased toxic effects of methotrexate on the bone marrow. Concomitant use with methotrexate at doses higher than 15 mg/week is contraindicated. Use with caution in the case of: uterine hemorrhage, excessive menstrual bleeding, use of an intrauterine contraceptive device, hypertension and heart failure. You should not drink alcohol during treatment due to the increased risk of damage to the gastrointestinal mucosa. In elderly patients, the product should be used in lower doses and at longer intervals due to the increased risk of side effects in this group of patients. Caution should be exercised when used in psychomotor agitated patients and patients suffering from insomnia. There is evidence that drugs that inhibit cyclooxygenase (an enzyme involved in the synthesis of prostaglandins) may cause fertility disorders in women by affecting ovulation. This effect is transient and disappears after the end of therapy. The product contains lactose monohydrate. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this product.